CEFUROXIME GLOB LIMITED

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

CEFUROXIME

Available from:

Glob Limited

Dosage:

125 Milligram

Pharmaceutical form:

Tablets

Authorization date:

2011-09-30

Summary of Product characteristics

                                
License
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Cefuroxime Glob Limited 125 mg Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 150.36 mg cefuroxime axetil equivalent to 125 mg cefuroxime.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
White to off-white, capsule shaped tablets with ‘A32’ debossed on one side and plain on the other side. The size is 12.5
mm X 5.0 mm.
4 CLINICAL PARTICULARS
4.1 Therapeutic Indications
Cefuroxime Glob Limited is indicated for the treatment of the following mild to moderately severe infections caused by
micro-organisms susceptible to cefuroxime:
•
upper respiratory tract infections: acute otitis media, sinusitis, tonsillitis and pharyngitis
•
acute bacterial bronchitis, acute exacerbations of chronic bronchitis
•
lower uncomplicated urinary tract infections: cystitis
•
skin and soft tissue infections: furunculosis, pyoderma and impetigo
•
treatment of early stage Lyme disease (stadium I) and subsequent prevention of late complications in adults and
children above 12 years of age.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
4.2 Posology and method of administration
Route 
                                
                                Read the complete document
                                
                            

Search alerts related to this product